SCHEMBL6560890

SCHEMBL6560890

Fc1ccc(F)cc1.[LiH]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL6770232 0.89 — —
Ammonia Solution, Strong SCHEMBL27741826 0.89 — —
Fluoride SCHEMBL21816906 0.89 CA1 (0.57) —
Ethyne SCHEMBL27932680 0.84 CA1 (0.53) —
Hydrazine SCHEMBL27364485 0.84 CA1 (0.53) —
Ethylene SCHEMBL27518912 0.84 CA1 (0.53) —
SCHEMBL10337645 0.80 BCL2L1 (0.55) —
SCHEMBL197346 0.80 BCL2L1 (0.55) —
SCHEMBL12562793 0.80 BCL2L1 (0.55) —
SCHEMBL10300262 0.80 BCL2L1 (0.55) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108658759-A A kind of preparation method of 2,3- difluoro-benzoic acids 河北凡克新材料有限公司 2018-10-16 — — CN claimed
EP-0876369-A1 2- 2- (2-HYDROXYETHYL)AMINO]ETHYL]-5- 2-METHYLAMINO)ETHYL]AMINO]INDAZOLO 4,3-gh]ISOQUINOLIN-6(2H)-ONE AS ANTITUMOR AGENT BOEHRINGER MANNHEIM ITALIA S.p.A. (IT) 1998-11-11 — — EP claimed
WO-1997010245-A1 2-[2-[(2-HYDROXYETHYL)AMINO]ETHYL]-5-[[2-METHYLAMINO)ETHYL]AMINO]INDAZOLO[4,3-gh]ISOQUINOLIN-6(2H)-ONE AS ANTITUMOR AGENT BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) 1997-03-20 — — WO claimed
CN-108658759-A A kind of preparation method of 2,3- difluoro-benzoic acids 河北凡克新材料有限公司 2018-10-16 — — CN disclosed
EP-1010702-B1 Process for preparing ortho-substituted aryl metal compounds and their conversion with electrophiles MERCK PATENT GMBH (DE) 2004-07-28 — — EP disclosed
EP-1010703-B1 Process for preparing aryl metal compounds and their conversion with electrophiles MERCK PATENT GMBH (DE) 2004-02-25 — — EP disclosed
US-6420584-B1 DEPROTONATION USING ALKYL- OR ARYLMETAL COMPOUNDS OR METAL HYDRIDES IN THE PRESENCE OF A CATALYTIC AMOUNT OF A SECONDARY METAL AMIDE. MERCK PATENT GMBH (DE) 2002-07-16 — — US disclosed
US-6207835-B1 DEPROTONATION IN CONTINUOUS FLOW REACTOR MERCK KGAA (DE) 2001-03-27 — — US disclosed
EP-1010702-A2 Process for preparing ortho-substituted aryl metal compounds and their conversion with electrophiles MERCK PATENT GmbH (DE) 2000-06-21 — — EP disclosed
EP-1010703-A2 Process for preparing aryl metal compounds and their conversion with electrophiles MERCK PATENT GmbH (DE) 2000-06-21 — — EP disclosed
US-6034092-A ANTITUMOR, ANTICANCER AGENTS NOVUSPHARMA S.P.A. (IT) 2000-03-07 — — US disclosed
EP-0876369-A1 2- 2- (2-HYDROXYETHYL)AMINO]ETHYL]-5- 2-METHYLAMINO)ETHYL]AMINO]INDAZOLO 4,3-gh]ISOQUINOLIN-6(2H)-ONE AS ANTITUMOR AGENT BOEHRINGER MANNHEIM ITALIA S.p.A. (IT) 1998-11-11 — — EP disclosed
EP-0440082-B1 Method for the conversion of fluorinated aromatic compounds using electrophiles MERCK PATENT GMBH (DE) 1998-04-15 — — EP disclosed
WO-1997010245-A1 2-[2-[(2-HYDROXYETHYL)AMINO]ETHYL]-5-[[2-METHYLAMINO)ETHYL]AMINO]INDAZOLO[4,3-gh]ISOQUINOLIN-6(2H)-ONE AS ANTITUMOR AGENT BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) 1997-03-20 — — WO disclosed
EP-0440082-A2 Method for the conversion of fluorinated aromatic compounds using electrophiles MERCK PATENT GmbH (DE) 1991-08-07 — — EP disclosed
Send feedback